Michael Perny

Michael Perny is a Medical Science Liaison Manager specializing in Immunology at Sanofi since 2022. Prior to this, they served as a Medical Science Liaison in Targeted Therapies and Immuno-Oncology at AstraZeneca from 2020 to 2022. Michael has an extensive educational background in Biomedical Sciences, holding a PhD, MSc, and BSc from Universität Bern, where they focused on critical topics such as pneumococcal meningitis and melanoma skin cancer. Additionally, Michael worked as a Human Geneticist at Dr. Risch and has contributed as a part-time lecturer in Molecular Oncology at medi, Zentrum für medizinische Bildung. They also have experience in software testing from their time at Swisscom Services AG.